Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
CIMAvax-EGF vaccine Predictor Phase IV
14/12/2015
Registered outdated
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab
12/05/2020
Registered outdated
NGcGM3/VSSP in small cell lung cancer
07/12/2016
Registered outdated
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma
05/11/2013
Registered outdated
Vaxira as adjuvant treatment for non-small cell lung cancer
15/12/2015
Registered outdated
Dose scale-up and cohort expansion with the therapeutic mAb 14F7
04/12/2015
Registered outdated
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma
01/09/2016
Registered outdated
Phase I/II trial with the mutein no alfa of IL-2
03/02/2017
Registered outdated
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT)
28/12/2018
Registered outdated
CIMAvax-EGF in patients at high risk of lung cancer
22/10/2020
Registered outdated
CIMAvax-EGF in Bladder cancer
11/08/2020
Registered outdated
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III.
01/10/2020
Registered outdated
NeuroEPO-Ataxia-Adults-Phase III
19/11/2020
Registered outdated
Phyisician Led CIMAvax-EGF lung biomarkers
11/03/2021
Registered outdated
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults
18/03/2021
Registered outdated
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM)
18/06/2021
Registered outdated
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX
21/05/2021
Registered outdated
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations
22/05/2021
Registered outdated
CIMAvax-EGF in different maintenance schemes
12/05/2021
Registered outdated
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders
18/06/2021
Registered outdated
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform